Onconova Therapeutics (ONTX) Reports Q2 Loss of $0.41/Share

Onconova Therapeutics (NASDAQ: ONTX) reported Q2 EPS of ($0.41), versus ($0.77) reported last year. Revenue for the quarter came in at $123 thousand, versus $125 thousand reported last year.

For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M